Filing Details
- Accession Number:
- 0001104659-23-036892
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2023-03-27 08:21:56
- Reporting Period:
- 2023-03-23
- Accepted Time:
- 2023-03-27 08:21:56
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1875558 | Nuvectis Pharma Inc. | NVCT | () | 4 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1251213 | Ron Bentsur | C/O Nuvectis Pharma, Inc 1 Bridge Plaza, Suite 275 Fort Lee NJ 07024 | Chairman & Ceo | Yes | Yes | Yes | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2023-03-23 | 230 | $12.13 | 3,228,329 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Footnotes
- Includes 96,759 shares of restricted stock and 330,000 restricted stock units.
Billionaire Hedge Funds
